移植后妊娠与避孕的临床综述
本文综述肾移植后女性与男性的妊娠、父育及避孕问题。强调移植后性功能改善及排卵月经早期恢复,需尽早开展生殖咨询;详述免疫抑制剂妊娠安全性数据、霉酚酸类对胎儿的风险及男性用药顾虑;讨论妊娠对移植物、胎儿和母亲的风险、哺乳期药物暴露及移植后育儿的伦理与现实。
要点
- 移植后应尽早开展生殖咨询,因性功能改善及排卵月经早期恢复
- 霉酚酸类对宫内胎儿有风险,但男性父育用药顾虑较少
- 妊娠对移植物、胎儿和母亲均有风险,需评估哺乳期免疫抑制剂暴露
核心结论
- 移植后需重视生殖咨询、避孕选择及免疫抑制剂妊娠安全性评估
- 霉酚酸类对宫内胎儿有风险,男性父育用药顾虑较少
- 妊娠对移植物、胎儿和母亲均存在风险,需关注哺乳期药物暴露
研究设计与样本
- 本文为概述性综述,聚焦移植后女性与男性的妊娠、父育和避孕问题
- 基于历史背景讨论移植后生殖相关问题
主要发现
- 移植后性功能改善及排卵月经早期恢复,早期生殖咨询至关重要
- 霉酚酸产品宫内暴露对胎儿有风险,男性父育使用顾虑较少
- 综述了免疫抑制剂妊娠安全性数据及婴儿经母乳暴露情况
临床怎么用
- 移植后应尽早提供生殖咨询并协助避孕选择决策
- 女性使用霉酚酸类需评估宫内胎儿风险,男性父育顾虑较少
- 妊娠需评估对移植物、胎儿和母亲的风险及哺乳期药物暴露
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Placed in a historical context, this overview focuses on post-transpant pregnancy, fatherhood, and contraception in women and men. The critical importance of early reproductive counseling because of improved sexual function and the early return of ovulation and menses post-transplant is emphasized. We explain the decision making regarding contraception choices. The available data on the safety of immunosuppressive drugs in pregnancy, and for men desiring fatherhood, are detailed. The risk of maternal ingestion of mycophenolate products on the in utero fetus is considered and contrasted with the lack of concern for their use by men fathering children. Pregnancy risks to the allograft, baby, and mother are discussed. An infant's exposure to specific immunosuppressant medications through breastfeeding is reviewed. The ethics and realities of post-transplant parenthood are explored.
引用
- Klein CL, Josephson MA. Post-Transplant Pregnancy and Contraception. Clin J Am Soc Nephrol. 2021. PMID: 33731339. doi:10.2215/CJN.14100820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。